SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bharat Parenterals informs about analyst meet

02 Mar 2024 Evaluate
Pursuant to Regulation 30 of the Listing Regulations read with clause 15(a) of Part A of Schedule III of the Listing Regulations, Bharat Parenterals has informed that two meeting is scheduled with the Analyst/ Institutional Investor for purpose of Investment in the Company on 6th March, 2024, in Mumbai. Further, the Investors' Presentations submitted vide its letter dated 20th February, 2024 and uploaded on website of the Company, will be made during the aforesaid meeting. The aforesaid information is also being placed on the website of the Company.
The above information is a part of company’s filings submitted to BSE.

Bharat Parenterals Share Price

1185.70 -27.40 (-2.26%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×